| Application no. and date | 18155337.1 (espacenet) (Federated) (European Patent Register), 20120427 | | Patent/reg. no. and date | DK/EP 3357497, 20201014 | | Publication date | 20180808 | | Priority no. and date | US 201161479817 P, 20110427, US 201261595009 P, 20120203 | | EP pub. no. and date |
EP 3357497 20180808 | | Effective date | | | Applicant/owner | Ionis Pharmaceuticals, Inc., 2855 Gazelle Court
Carlsbad, CA 92010, US | | Applicant ref. no. | P74436DK01 | | Inventor | MULLICK, Adam, 2855 Gazelle Court
Carlsbad, CA California 92010, US,
CROOKE, Rosanne, M., 2855 Gazelle Court
Carlsbad, CA California 92010, US,
GRAHAM, Mark, J., 2855 Gazelle Court
Carlsbad, CA California 92010, US,
DOBIE, Kenneth, W., 703 Stratford Ct. 4
Del Mar, CA California 92014, US,
BELL, Thomas, A., 2855 Gazelle Court
Carlsbad, CA California 92010, US,
LEE, Richard, 2855 Gazelle Court
Carlsbad, CA California 92010, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/7088 (2006.01) , A61P 3/06 (2006.01) | | Title | MODULATION AF APOLIPOPROTEIN CIII (APOCIII) EKSPRESSION | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
